Robust Potency Assay Strategies: Lessons Learned from Clinical Development

Time: 3:15 pm
day: Conference Day One


  • Defining a potency assay approach based on the disease mechanism-of-action
  • Learning from a successful potency assay strategy for IND clearance
  • Sharing a case study of adapting a potency assay matrix strategy through early- to late-stage development